CTRI/2018/11/016292已完成3 期
Role of oral fluconazole in reducing disease activity in patients of active ulcerative colitis : A double blind randomised placebo controlled trial
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- PGIMER
- 入组人数
- 61
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Consecutive diagnosed cases of UC who are willing to participate in the study after signing the consent form
排除标准
- •1.Unable to provide informed consent
- •2Pregnant/ Lactating mother
- •3.Renal/Hepatic disorder
- •4.Serious life threatening co morbidity
- •5.Patients who are exposed to anti-fungal drugs in last 1 month
研究者
相似试验
已完成
不适用
Fluconazole in the prevention of infection in neonatesCandidiasisIRCT20170215032587N4Ghoum University of Medical Sciences120
已完成
不适用
Prophylactic fluconazole is effective in preventing fungal colonisation and infection in preterm neonates: a multicentre, randomised trial in Italyeonatal fungal infectionNeonatal DiseasesNeonatal fungal infectionISRCTN85753869Saint Anna Foundation (Fondazione Crescere Insieme al Santa Anna [ONLUS]) (Italy)267
招募中
3 期
The effect of fluconazole lozenge on oral candidiasisOral candidiasis.Candidal stomatitisB37.0IRCT20191106045356N16Yazd University of Medical Sciences50
已完成
1 期
A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the BloodHealthyNCT05076409Boehringer Ingelheim15
进行中（未招募）
1 期
Supplementary effect of antimycotics in the treatment of destructive gum disease – A placebo-controlled, blind, randomized clinical trialPeriodontitis.The participants are in good general health, but have at least 2 residual dental lesions after periodontal treatment (standard care).MedDRA version: 20.1Level: LLTClassification code 10009102Term: Chronic periodontitisSystem Organ Class: 100000004862EUCTR2019-003541-15-DKAarhus University84